Piyasa Haberleri

En güncel finans ve ekonomi haberlerini, piyasa gelişmelerini, raporları ve analizleri PipVero’da takip edin.

Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Arista Networks: Despite Clear AI Tailwinds, Gains Will Be More Limited Here (Downgrade)

Arista Networks: Despite Clear AI Tailwinds, Gains Will Be More Limited Here (Downgrade)

Arista Networks has surged to all-time highs, driven by ~40% revenue and earnings growth amid robust AI data center demand. ANET's 'AI spine' products have become the gold standard for modern data centers, cementing its leadership over legacy competitors like Cisco. Despite outstanding Rule of 40 performance (~80), margin pressures from memory shortages and concerns over one-time sales temper the bullish case.

İlgili Semboller 1
ANET ANET
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: GlobeNewsWire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
FUTU FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Futu Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FUTU

FUTU FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Futu Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FUTU

NEW YORK, Aug. 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Futu Holdings Limited (NASDAQ: FUTU) between May 24, 2023 and May 27, 2026, inclusive (the “Class Period”), of the important August 25, 2026 lead plaintiff deadline.

İlgili Semboller 1
FUTU FUTU
Kaynak: GlobeNewsWire
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: GlobeNewsWire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX

TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX

NEW YORK, Aug. 08, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX).

İlgili Semboller 1
TMDX TMDX
Kaynak: GlobeNewsWire
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: MarketBeat Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Ralph Lauren Q1 Earnings Call Highlights

Ralph Lauren Q1 Earnings Call Highlights

Ralph Lauren NYSE: RL reported first-quarter fiscal 2027 results that exceeded its expectations, with revenue rising 13% on a constant-currency basis and adjusted operating margin expanding 150 basis points to 18.5%.

İlgili Semboller 1
RL RL
Kaynak: MarketBeat
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: MarketBeat Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Rocket Companies Q2 Earnings Call Highlights

Rocket Companies Q2 Earnings Call Highlights

Rocket Companies NYSE: RKT reported second-quarter 2026 results that it described as its most profitable quarter in four years, despite what management characterized as one of the housing industry's toughest spring markets in recent years.

İlgili Semboller 1
RKT RKT
Kaynak: MarketBeat
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: MarketBeat Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Transocean Q2 Earnings Call Highlights

Transocean Q2 Earnings Call Highlights

Transocean NYSE: RIG reported second-quarter results that exceeded its prior revenue and cost guidance, supported by 98% fleet uptime, contract additions and lower-than-expected operating expenses. The offshore drilling contractor also said it expects to close its acquisition of Valaris in the fourth quarter, pending remaining regulatory approvals.

İlgili Semboller 1
RIG RIG
Kaynak: MarketBeat
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: MarketBeat Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Ryman Hospitality Properties Q2 Earnings Call Highlights

Ryman Hospitality Properties Q2 Earnings Call Highlights

Ryman Hospitality Properties NYSE: RHP said its same-store hospitality business outperformed its internal expectations in the second quarter, supported by higher group rates, stronger catering spending and continued demand for premium meetings business.

İlgili Semboller 1
RHP RHP
Kaynak: MarketBeat
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: MarketBeat Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Reinsurance Group of America Q2 Earnings Call Highlights

Reinsurance Group of America Q2 Earnings Call Highlights

Reinsurance Group of America NYSE: RGA reported a record operating quarter in the second quarter of 2026, supported by investment income, recent new business, and modestly favorable claims experience across its global operations.

İlgili Semboller 1
RGA RGA
Kaynak: MarketBeat
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: MarketBeat Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Redwire Q2 Earnings Call Highlights

Redwire Q2 Earnings Call Highlights

Redwire NYSE: RDW reported record second-quarter revenue, gross margin and contracted backlog for 2026, as growth in its defense technology business and continued demand for space systems supported results. The company reaffirmed its full-year revenue outlook and said it expects revenue to build during the second half.

İlgili Semboller 1
RDW RDW
Kaynak: MarketBeat
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: MarketBeat Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Radian Group Q2 Earnings Call Highlights

Radian Group Q2 Earnings Call Highlights

Radian Group NYSE: RDN reported second-quarter results that reflected its first full quarter including specialty insurer Inigo, while executives emphasized continued strength in mortgage insurance, progress on divestitures and disciplined capital deployment amid a softer specialty insurance market.

İlgili Semboller 1
RDN RDN
Kaynak: MarketBeat
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: MarketBeat Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Arcus Biosciences Q2 Earnings Call Highlights

Arcus Biosciences Q2 Earnings Call Highlights

Arcus Biosciences NYSE: RCUS outlined plans to expand development of its casdatifan cancer program across multiple lines of clear cell renal cell carcinoma, or ccRCC, while reporting second-quarter financial results and updates on its pancreatic cancer and immunology pipelines.

İlgili Semboller 1
RCUS RCUS
Kaynak: MarketBeat
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: MarketBeat Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Ready Capital Q2 Earnings Call Highlights

Ready Capital Q2 Earnings Call Highlights

Ready Capital NYSE: RC said its second-quarter results reflected continued progress in a balance sheet repositioning plan, including portfolio sales, debt paydowns and new financing initiatives, as the company works to meet remaining 2026 debt maturities and return to sustainable profitability.

İlgili Semboller 1
RC RC
Kaynak: MarketBeat
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Coupang: Beyond The Noise, User Recovery And Taiwan Point To Attractive Upside

Coupang: Beyond The Noise, User Recovery And Taiwan Point To Attractive Upside

Coupang is recovering from a data breach, with underlying fundamentals and customer spend showing resilience and platform stickiness. CPNG's Korea operations remain highly profitable, while accelerated logistics investment positions Taiwan as the next potential profit engine. Despite near-term headwinds, CPNG trades at a historical low 0.7–0.8x forward revenue multiple, implying significant upside if re-rated to peer averages.

İlgili Semboller 1
CPNG CPNG
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
Yorum Yap
Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
AdvanSix: Challenges Persist, My Downgrade Was Correct

AdvanSix: Challenges Persist, My Downgrade Was Correct

AdvanSix (ASIX) faces significant short-term headwinds, with a 90% net income drop and negative FCF in 2Q26, driving a >20% share price decline. ASIX's structurally advantageous single-feedstock model is outweighed by weak end-market demand, limited pricing power, and high exposure to cyclical sectors like fertilizers and nylon. I lower my price target to $16/share, reflecting prolonged macro weakness and industry overcapacity; recovery is expected to take 5-6 quarters or longer.

İlgili Semboller 1
ASIX ASIX
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
Yorum Yap